The Cancer Health Outcomes and Control Program conducts research aimed at reducing the burden of cancer across the entire cancer care continuum. The research efforts of this interdisciplinary, collaborative program center on the themes of:
The Cancer Epidemiology Research Program aims to improve our understanding of the genetic and environmental origins of cancer and to identify biomarkers for cancer risk and progression. This understanding informs the design of effective cancer prevention and control programs.
The Translational Research and Interventional Oncology Research Program is an integrated multi-disciplinary program that provides the opportunity for clinical investigators and laboratory scientists to collaboratively address the rapidly changing landscape of cancer therapy. The program traverses multiple disciplines, including precision oncology, immuno-oncology, cellular therapy, and immune-toxicity.
Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC)
